RBC Capital reported LDR's stock had the "outperform" rating reissued earlier this week, according to a Ticker Report.
RBC Capital assumed LDR share coverage in June.
Here are five things to know about the company's stock:
• Price target: $34
• Potential upside: 9.25 percent from the stock's previous close
• LDR traded up 1.08 percent mid-day Monday
• Market cap: $313.2 million
• Average volume: 55,9985
Piper Jaffray separately raised LDR's price target from $38 to $40 in early August, and they now have an "overweight" rating on the stock. An additional five equities research analysis gave LDR a "Buy" rating with $35.50 as the price target, according to the report.
The company reported total revenue was up 30.7 percent for the second quarter of 2014 to $34.8 million. Exclusive technology products grew 40.9 percent to $30 million in the quarter. Overall revenue in the United States was up 40 percent to $26.3 million.
LDR increased revenue guidance for the full year 20 percent to 21 percent, which would put the company at around $134 million to $135 million for the year. This would be a 15 percent to 16 percent growth over 2013.
More articles on orthopedic devices:
Spine Wave launches access product portfolio
Amedica, Spinal Kinetics partner
20 spine devices receive FDA 510(k) clearance in September